Contemporary Concepts in Atrial Fibrillation Ablation

Login or register to view PDF.
Citation
US Cardiology 2006;2005:2(1):182-185

Pages

Atrial fibrillation (AF) affects approximately two million people in the US. It is a major cause of stroke, adversely impacts quality of life, and is associated with increased mortality.1-4 Treatment with antiarrhythmic drugs and anticoagulation is still considered first-line therapy in patients with symptomatic AF.

Recent randomized trials4,5 have shown that a strategy of rate control and anticoagulation as indicated is comparable with a strategy of rhythm control using antiarrhythmic drugs in treating many patients with AF. In these trials,4,5 mostly elderly patients had well tolerated AF. Restoring sinus rhythm may be of greater benefit in younger patients because doing so may prevent the progressive atrial remodeling that leads to chronic AF.6

These studies only showed that a strategy of rhythm control using antiarrhythmic drugs was comparable with a strategy of rate control without using antiarrhythmic drugs. A limitation of all these trials is that the rhythm control strategy was not efficacious. For example, in one trial,4 only 39% of patients randomized to the antiarrhythmic drug group were in sinus rhythm at the end of the study. Furthermore, in an analysis of one study7 that evaluated predictors of mortality, sinus rhythm was associated with a 47% reduction in risk of death, whereas use of antiarrhythmic drug therapy was associated with a 49% increase in mortality. This suggests that the neutral results in the rate control compared with rhythm control trials might be explained by the fact that offsetting the detrimental effects of antiarrhythmic drug therapy negated the benefits of antiarrhythmic drugs in restoring sinus rhythm. In theory, a therapy that restores and maintains sinus rhythm while avoiding the deleterious effects of automatic atrial defibrillators (AADs) would improve survival. AF catheter ablation would be one such therapy.

In contrast to antiarrhythmic medications, catheter ablation eliminates the triggers of AF. Haissaguerre et al.8 showed that the triggers of AF originate from the pulmonary veins in most patients with AF. Only a minority of patients have extra-pulmonary vein foci as triggers of AF. The pulmonary veins have been shown to play a critical role in both triggering and maintaining AF. The goal of present-day AF ablation (AFA) is to electrically 'disconnectÔÇÖ the pulmonary veins from the rest of the atrium by ablating around the origin of the veins. Currently, there are at least two techniques of AFAÔÇöa purely anatomical approach, guided by non-fluoroscopic navigation systems. In these anatomically guided techniques, radio frequency ablations (RFA) are delivered circumferentially outside the pulmonary vein ostia with a variety of additional ablation lesions.9

Pages

References
  1. Hohnloser S H, Kuck K H, Randomized trial of rhythm or rate control in atrial fibrillation: the Pharmacological Intervention in Atrial Fibrillation Trial (PIAF), Eur. Heart J. (2001);22: pp. 801-812.
    Crossref | PubMed
  2. Go A S, Hylek E M, Phillips K A et al., Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study, JAMA (2001);285: pp. 2,370-2,375.
    Crossref | PubMed
  3. Narasimhan C, Blanck Z, Akhtar M, Atrioventricular nodal modification and atrioventricular junctional ablation for control of ventricular rate in atrial fibrillation, J. Cardiovasc. Electrophysiol. (1998);9:S146-150.
    PubMed
  4. Wyse D G,Waldo A L, DiMarco J P et al.,A comparison of rate control and rhythm control in patients with atrial fibrillation, N. Engl. J. Med. (2002);347: pp. 1,825-1,233.
    Crossref | PubMed
  5. Van Gelder I C, Hagens V E, Bosker H A et al., A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation, N. Engl. J. Med. (2002);347: pp. 1,834-1,840.
    Crossref | PubMed
  6. Wijffels M C, Kirchhof C J, Dorland R, Allessie M A,Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats, Circulation (1995);92: pp. 1,954-1,968.
    Crossref | PubMed
  7. Corley S D, Epstein A E, DiMarco J P et al., Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study, Circulation (2004);109: pp. 1,509-1,513.
    Crossref | PubMed
  8. Haissaguerre M, Jais P, Shah D C et al.,Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins, N. Engl. J. Med. (1998);339: pp. 659-666.
    Crossref | PubMed
  9. Cappato R, Calkins H, Chen S A et al.,Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation, Circulation (2005);111: pp. 1,100-1,105.
    Crossref | PubMed
  10. Marrouche N F, Martin D O,Wazni O et al., Phased array intracardiac echocardiography monitoring during pulmonary vein isolation in patients with atrial fibrillation: impact on outcome and complications, Circulation, in press.
  11. Wazni O M, Rossillo A, Marrouche N F et al.,Embolic events and char formation during pulmonary vein isolation in patients with atrial fibrillation: impact of different anticoagulation regimens and importance of intracardiac echo imaging, J. Cardiovasc. Electrophysiol. (2005);16: pp. 576-581.
    Crossref | PubMed
  12. Verma A, Marrouche N F, Natale A, Pulmonary vein antrum isolation: intracardiac echocardiography-guided technique, J. Cardiovasc. Electrophysiol. (2004);15: pp. 1,335-1,340.
    Crossref | PubMed
  13. Wazni O M, Marrouche N F, Martin D O et al., Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial, JAMA (2005);293: pp. 2,634-2,640.
    Crossref | PubMed
  14. Pappone C, Oral H, Santinelli V et al.,Atrio-esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation, Circulation (2004);109: pp. 2,724-2,726.
    Crossref | PubMed
  15. Sonmez B, Demirsoy E,Yagan N et al.,A fatal complication due to radiofrequency ablation for atrial fibrillation: atrio-esophageal fistula, Ann.Thorac. Surg. (2003);76: pp. 281-283.
    Crossref | PubMed